• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管内皮生长因子和碱性成纤维细胞生长因子基因表达在肝肿瘤中的临床意义

Clinical significance of vascular endothelial growth factor and basic fibroblast growth factor gene expression in liver tumor.

作者信息

Mise M, Arii S, Higashituji H, Furutani M, Niwano M, Harada T, Ishigami S, Toda Y, Nakayama H, Fukumoto M, Fujita J, Imamura M

机构信息

First Department of Surgery, Faculty of Medicine, Kyoto University, Japan.

出版信息

Hepatology. 1996 Mar;23(3):455-64. doi: 10.1053/jhep.1996.v23.pm0008617424.

DOI:10.1053/jhep.1996.v23.pm0008617424
PMID:8617424
Abstract

Hepatocellular carcinoma (HCC) is a typical hypervascular tumor. However, the relationship between the vascularity of HCC and the expression of angiogenic factors has not been investigated. In addition, no detailed studies have examined the possible involvement of angiogenic factors in the grade of malignancy of HCC. The aim of this study was to determine which angiogenic factors regulate tumor angiogenesis and contribute to the invasive ability of liver tumors, especially of HCC. Northern blot analysis was used to examine the transcriptional expression of vascular endothelial growth factor (VEGF), basic fibroblast growth factor (FGF), and acidic FGF in resected surgical specimens (20 HCC and 9 metastatic liver tumors). Correlations between messenger RNA (mRNA) expression and arteriographic findings, as well as histopathological findings, were evaluated. Immunohistochemistry was performed to identify the localization of cells expressing VEGF in HCC. Higher levels of VEGF mRNA were observed in 12 of 20 HCC and 2 of 9 metastatic liver tumors than in corresponding nontumorous tissues. The degree of VEGF mRNA expression was significantly correlated with the intensity of tumor staining in angiograms (P<.01). On immunohistochemical observation, VEGF protein was intensely detected in HCC cells. Furthermore, basic FGF mRNA was detected in 9 of 20 HCC and was related to the capsular infiltration of cancer cells (P<.05). In contrast, no significant difference was observed in the very low levels of acidic FGF mRNA found in the tumorous and nontumorous portions of the liver. In conclusion, these results suggest that VEGF contributes to angiogenesis of liver tumors, whereas basic FGF may be involved in the invasion of HCC into the surrounding tissues.

摘要

肝细胞癌(HCC)是一种典型的富血管肿瘤。然而,HCC的血管生成与血管生成因子表达之间的关系尚未得到研究。此外,尚无详细研究探讨血管生成因子是否可能参与HCC的恶性程度。本研究的目的是确定哪些血管生成因子调节肿瘤血管生成并促进肝肿瘤尤其是HCC的侵袭能力。采用Northern印迹分析检测20例HCC手术切除标本和9例肝转移瘤手术切除标本中血管内皮生长因子(VEGF)、碱性成纤维细胞生长因子(FGF)和酸性FGF的转录表达。评估信使核糖核酸(mRNA)表达与血管造影结果以及组织病理学结果之间的相关性。进行免疫组织化学以确定HCC中表达VEGF的细胞的定位。在20例HCC中的12例和9例肝转移瘤中的2例中观察到VEGF mRNA水平高于相应的非肿瘤组织。VEGF mRNA表达程度与血管造影中肿瘤染色强度显著相关(P<0.01)。免疫组织化学观察发现,HCC细胞中强烈检测到VEGF蛋白。此外,在20例HCC中的9例中检测到碱性FGF mRNA,且与癌细胞的包膜浸润有关(P<0.05)。相比之下,在肝肿瘤和非肿瘤部分中检测到的酸性FGF mRNA水平极低,未观察到显著差异。总之,这些结果表明VEGF促进肝肿瘤血管生成,而碱性FGF可能参与HCC向周围组织的侵袭。

相似文献

1
Clinical significance of vascular endothelial growth factor and basic fibroblast growth factor gene expression in liver tumor.血管内皮生长因子和碱性成纤维细胞生长因子基因表达在肝肿瘤中的临床意义
Hepatology. 1996 Mar;23(3):455-64. doi: 10.1053/jhep.1996.v23.pm0008617424.
2
Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver.微血管密度和血管内皮生长因子表达在肝细胞癌及周围肝组织中的临床意义:血管内皮生长因子可能参与肝硬化肝脏的血管生成
Hepatology. 1998 Jun;27(6):1554-62. doi: 10.1002/hep.510270613.
3
Significance of vascular endothelial growth factor mRNA expression in invasion and metastasis of hepatocellular carcinoma.血管内皮生长因子mRNA表达在肝细胞癌侵袭和转移中的意义
J Exp Clin Cancer Res. 1998 Mar;17(1):13-7.
4
Microvessel density, vascular endothelial growth factor and its receptors Flt-1 and Flk-1/KDR in hepatocellular carcinoma.肝细胞癌中的微血管密度、血管内皮生长因子及其受体Flt-1和Flk-1/KDR
Am J Clin Pathol. 2001 Dec;116(6):838-45. doi: 10.1309/FXNL-QTN1-94FH-AB3A.
5
[Expression of vascular endothelial growth factor correlates with invasion and metastasis of hepatocellular carcinoma].血管内皮生长因子的表达与肝细胞癌的侵袭和转移相关
Zhonghua Zhong Liu Za Zhi. 1998 Jan;20(1):12-4.
6
Overexpression of VEGF and angiopoietin 2: a key to high vascularity of hepatocellular carcinoma?血管内皮生长因子(VEGF)和血管生成素2的过表达:肝细胞癌高血管化的关键因素?
Mod Pathol. 2003 Jun;16(6):552-7. doi: 10.1097/01.MP.0000071841.17900.69.
7
Expression of vascular endothelial growth factor in human hepatocellular carcinoma.血管内皮生长因子在人肝细胞癌中的表达
Hepatology. 1998 Jul;28(1):68-77. doi: 10.1002/hep.510280111.
8
Insulin-like growth factor II induced by hypoxia may contribute to angiogenesis of human hepatocellular carcinoma.缺氧诱导的胰岛素样生长因子II可能有助于人类肝细胞癌的血管生成。
Cancer Res. 1998 Jan 15;58(2):348-51.
9
Synergistic effect of basic fibroblast growth factor and vascular endothelial growth factor in murine hepatocellular carcinoma.碱性成纤维细胞生长因子与血管内皮生长因子在小鼠肝细胞癌中的协同作用
Hepatology. 2002 Apr;35(4):834-42. doi: 10.1053/jhep.2002.32541.
10
Enhanced expression of thrombospondin-1 and hypovascularity in human cholangiocarcinoma.血小板反应蛋白-1在人胆管癌中的表达增强及血管生成不足
Hepatology. 1998 Dec;28(6):1512-7. doi: 10.1002/hep.510280610.

引用本文的文献

1
Hypoxia as a Target for Combination with Transarterial Chemoembolization in Hepatocellular Carcinoma.缺氧作为肝细胞癌经动脉化疗栓塞联合治疗的靶点
Pharmaceuticals (Basel). 2024 Aug 11;17(8):1057. doi: 10.3390/ph17081057.
2
Role of Epiregulin on Lipopolysaccharide-Induced Hepatocarcinogenesis as a Mediator via EGFR Signaling in the Cancer Microenvironment.表皮调节素在癌症微环境中作为通过表皮生长因子受体信号传导的介质对脂多糖诱导的肝癌发生的作用。
Int J Mol Sci. 2024 Apr 17;25(8):4405. doi: 10.3390/ijms25084405.
3
Hepatocellular Carcinoma: Old and Emerging Therapeutic Targets.
肝细胞癌:既往及新出现的治疗靶点
Cancers (Basel). 2024 Feb 23;16(5):901. doi: 10.3390/cancers16050901.
4
Mechanisms of resistance to anti-angiogenic treatments.抗血管生成治疗的耐药机制。
Cancer Drug Resist. 2019 Sep 19;2(3):595-607. doi: 10.20517/cdr.2019.39. eCollection 2019.
5
Methylene tetrahydrofolate reductase (MTHFR) and vascular endothelial growth factor (VEGF) polymorphisms in Brazilian patients with Hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC).巴西丙型肝炎病毒(HCV)相关肝细胞癌(HCC)患者中亚甲基四氢叶酸还原酶(MTHFR)和血管内皮生长因子(VEGF)多态性。
Clinics (Sao Paulo). 2021 Oct 11;76:e2881. doi: 10.6061/clinics/2021/e2881. eCollection 2021.
6
Evaluation of anticancer effects of Juniperus communis extract on hepatocellular carcinoma cells in vitro and in vivo.评价杜松提取物在体外和体内对肝癌细胞的抗癌作用。
Biosci Rep. 2021 Jul 30;41(7). doi: 10.1042/BSR20211143.
7
Bevacizumab Augments the Antitumor Efficacy of Infigratinib in Hepatocellular Carcinoma.贝伐珠单抗增强了英菲格拉替尼治疗肝细胞癌的抗肿瘤疗效。
Int J Mol Sci. 2020 Dec 10;21(24):9405. doi: 10.3390/ijms21249405.
8
Vascular co-option and vasculogenic mimicry mediate resistance to antiangiogenic strategies.血管选择和血管生成拟态介导了对血管生成抑制策略的抵抗。
Cancer Rep (Hoboken). 2022 Dec;5(12):e1318. doi: 10.1002/cnr2.1318. Epub 2020 Dec 9.
9
Triggered ROS-Induced DNA Damage to Arrest Cell Cycle Progression and Induce Apoptosis on Human Hepatocellular Carcinoma In Vitro and In Vivo.ROS 诱导的 DNA 损伤可阻止人肝癌细胞周期进程并诱导其凋亡:体内外研究。
Molecules. 2020 Nov 30;25(23):5639. doi: 10.3390/molecules25235639.
10
The Crosstalk between Tumor Cells and the Microenvironment in Hepatocellular Carcinoma: The Role of Exosomal microRNAs and their Clinical Implications.肝细胞癌中肿瘤细胞与微环境之间的串扰:外泌体微小RNA的作用及其临床意义
Cancers (Basel). 2020 Mar 29;12(4):823. doi: 10.3390/cancers12040823.